Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus

Inflammation

Volumn 31, Issue 3, 2008, Pages 146-153

  Koca, Suleyman Serdar ^a   Isik, Ahmet ^a   Ustundag, Bilal ^a   Metin, Kerem ^a   Aksoy, Kader ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Anemia of chronic disease; Pro hepcidin; Rheumatoid arthritis

Indexed keywords

FERRITIN; HORMONE PRECURSOR; INTERLEUKIN 6; IRON; PROHEPCIDIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANEMIA; ANTIMICROBIAL CATIONIC PEPTIDES; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; FERRITINS; HUMANS; INTERLEUKIN-6; IRON; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43349088037     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-008-9060-8     Document Type: Article

References (42)

1. Means, R. T., and S. B. Krantz. 1992. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639-1647.
2. Means, R. T. 1999. Advances in the anemia of chronic disease. Int. J. Hematol. 70:7-12.
3. Weiss, G., and L. T. Goodnough. 2005. Anemia of chronic disease. N. Engl. J. Med. 352:1011-1023.
4. Das Gupta, A., and A. Abbi. 2003. High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency. Am. J. Hematol. 72:158-161.
5. Alvarez-Hernandez, X., J. Liceaga, I. C. McKay, and J. H. Brock. 1989. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab. Invest. 61:319-322.
6. Moldawer, L. L., M. A. Marano, H. Wei, Y. Fong, M. L. Silen, G. Kuo, K. R. Manogue, H. Vlassara, H. Cohen, A. Cerami, and S. F. Lowry. 1989. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 3:1637-1643.
7. Faquin, W. C., T. J. Schneider, and M. A. Goldberg. 1992. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79:1987-1894.
8. Papadaki, H. A., H. D. Kritikos, V. Valatas, D. T. Boumpas, and G. D. Eliopoulos. 2002. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 100:474-482.
9. Torti, F. M., and S. V. Torti. 2002. Regulation of ferritin genes and protein. Blood 99:3505-3516.
10. Maury, C. P., L. C. Andersson, A. M. Teppo, S. Partanen, and E. Juvonen. 1988. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann. Rheum. Dis. 47:972-978.
11. Nemeth, E., M. S. Tuttle, J. Powelson, M. B. Vaughn, A. Donovan, D. M. Ward, T. Ganz, and J. Kaplan. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093.
12. Nemeth, E., S. Rivera, V. Gabayan, C. Keller, S. Taudorf, B. K. Pedersen, and T. Ganz. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113:1271-1276.
13. Pigeon, C., G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot, and O. Loreal. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276:7811-7819.
14. Nicolas, G., C. Chauvet, L. Viatte, J. L. Danan, X. Bigard, I. Devaux, C. Beaumont, A. Kahn, and S. Vaulont. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110:1037-1044.
15. Nemeth, E., E. V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463.
16. Vyoral, D., and J. Petrak. 2005. Hepcidin: a direct link between iron metabolism and immunity. Int. J. Biochem. Cell Biol. 37:1768-1773.
17. Tomosugi, N., H. Kawabata, R. Wakatabe, M. Higuchi, H. Yamaya, H. Umehara, and I. Ishikawa. 2006. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System(R). Blood 108:1381-1387.
18. Kulaksiz, H., S. G. Gehrke, A. Janetzko, D. Rost, T. Bruckner, B. Kallinowski, and W. Stremmel. 2004. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 53:735-743.
19. Kemna, E., H. Tjalsma, C. Laarakkers, E. Nemeth, H. Willems, and D. Swinkels. 2005. Novel urine hepcidin assay by mass spectrometry. Blood 106:3268-3270.
20. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315-324.
21. Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1725.
22. Leeb, B. F., I. Andel, J. Sautner, M. Bogdan, A. Maktari, T. Nothnagl, and B. Rintelen. 2005. Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis Rheum. 53:56-60.
23. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang. 1992. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35:630-640.
24. Kulaksiz, H., F. Theilig, S. Bachmann, S. G. Gehrke, D. Rost, A. Janetzko, Y. Cetin, and W. Stremmel. 2005. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J. Endocrinol. 184:361-370.
25. Giannouli, S., M. Voulgarelis, P. D. Ziakas, and A. G. Tzioufas. 2006. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann. Rheum. Dis. 65:144-148.
26. Glossop, J. R., P. T. Dawes, A. B. Hassell, and D. L. Mattey. 2005. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes. J. Rheumatol. 32:1673-1678.
27. Hansen, T. M., N. E. Hansen, H. S. Birgens, B. Holund, and I. Lorenzen. 1983. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand. J. Rheumatol. 12:353-359.
28. Lee, P., H. Peng, T. Gelbart, L. Wang, and E. Beutler. 2005. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. U. S. A. 102:1906-1910.
29. Keeling, D. M., and D. A. Isenberg. 1993. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 7:199-207.
30. Canete, J. D., S. E. Martinez, J. Farres, R. Sanmarti, M. Blay, A. Gomez, G. Salvador, and J. Munoz-Gomez. 2000. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann. Rheum. Dis. 59:263-268.
31. Hagiwara, E. N., M. F. Gourley, S. Lee, and D. M. Klinman. 1996. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of Interleukin-10: Interferon-γ secreting cells in the peripheral blood. Arthritis Rheum. 39:379-385.
32. Malyszko, J., J. S. Malyszko, T. Hryszko, K. Pawlak, and M. Mysliwiec. 2005. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients? Am. J. Nephrol. 25:586-590.
33. Vreugdenhil, G., B. Lowenberg, H. G. Van Eijk, and A. J. Swaak. 1992. Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur. J. Clin. Invest. 22:488-493.
34. Roodman, G. D., R. A. Johnson, and U. Clibon. 1989. Tumor necrosis factor alpha and the anemia of chronic disease: effects of chronic exposure to TNF on erythropoiesis in vivo. Adv. Exp. Med. Biol. 271:185-196.
35. Jongen-Lavrencic, M., H. R. Peeters, B. Backx, I. P. Touw, G. Vreugdenhil, and A. J. Swaak. 1994. R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis. Rheumatol. Int. 14:109-113.
36. Theurl, I., V. Mattle, M. Seifert, M. Mariani, C. Marth, and G. Weiss. 2006. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 107:4142-4148.
37. Dallalio, G., T. Fleury, and R. T. Means. 2003. Serum hepcidin in clinical specimens. Br. J. Haematol. 122:996-1000.
38. Nagashima, M., M. Kudo, H. Chung, E. Ishikawa, S. Hagiwara, T. Nakatani, and K. Dote. 2006. Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol. Res. 36:288-293.
39. Taes, Y. E., B. Wuyts, J. R. Boelaert, A. S. De Vriese, and J. R. Delanghe. 2004. Prohepcidin accumulates in renal insufficiency. Clin. Chem. Lab. Med. 42:387-389.
40. Roe, M. A., C. Spinks, A. L. Heath, L. J. Harvey, R. Foxall, J. Wimperis, C. Wolf, and S. J. Fairweather-Tait. 2007. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br. J. Nutr. 97:544-549.
41. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397-440.
42. Bridges, S. L., and A. Davidson. 2005. Rheumatoid factor. In: Arthritis and allied conditions a textbook of rheumatology, Koppman, W. J., and L. W. Moreland eds. 15th ed. Lippincot Williams and Wilkins, Philadelphia, pp. 1227-1247.